Post-approval studies (Phase 4)UnknownNCT01515878
What this trial is testing
Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS
Who this might be right for
Kidney Failure ChronicCardiovascular Diseases
IRCCS Azienda Ospedaliero-Universitaria di Bologna 396